Right first time: Pioneering new methods of drug manufacture

Nov 11, 2009

Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation.

Ensuring drug crystals are formed correctly is crucial to their efficacy and the efficiency of pharmaceutical manufacturers' operations. Using self-assembled monolayers, the team has been able to show that crystals form into their desired product form with the correct shape and particle structure, without the usual problems of polymorphism which results in huge losses to the pharmaceutical sector each year.

"If you imagine the way that oil sits on top of water, that's similar to how the monolayer works," says Professor Kevin Roberts of University's Faculty of Engineering. "We've shown that we can produce a well-defined using a self-assembled monolayer bound onto a metal substrate within a regular reactor. This is exciting stuff, because it's a relatively simple system, but could make a huge difference in the efficiency of drug manufacture."

One of the first stages of the crystallisation process is called nucleation. During nucleation, particles are introduced into a reactor to encourage the formation of crystals. However, the way in which this is currently carried out is difficult to control and can often lead to the wrong shape, size or structure of drug crystal, something which affects the usefulness and efficacy of the compound.

The new system proven to work by the Leeds team, working alongside Ana Kwokal from Croatian pharmaceutical company PLIVA, has shown that introducing a self-assembled monolayer - a layer of self-organising molecules that is attractive to the substance being crystallised - into a reactor enables consistent crystal formation.

Professor Roberts says: "Because this is a really simple solution to ensuring consistent crystallisation, it has huge potential commercially. Our next steps are to make sure it's just as efficient on an industrial scale."

This work draws on previous research and experimental systems developed through the Chemicals Behaving Badly II initiative, an Engineering and Physical Sciences Research Council (EPSRC) programme which includes universities and industrial partners.

Source: University of Leeds (news : web)

Explore further: A dye with tunable optical characteristics

add to favorites email to friend print save as pdf

Related Stories

New tool for 'right first time' drug manufacture

Sep 22, 2008

A technology which provides high quality images of the crystallisation process marks the next step towards a 'right first time' approach to drug manufacture, according to engineers at the University of Leeds.

Crystal clear savings for drug giants

Jun 06, 2008

Drug companies could save millions thanks to a new technology to monitor crystals as they form. The technique, developed by University of Leeds engineers, is a potentially invaluable tool in drug manufacture, ...

Crystal to glass cooling model developed

Feb 22, 2006

University of Tokyo scientists have discovered why cooling sometimes causes liquid molecules to form disordered glasses, rather than ordered crystals.

Recommended for you

A dye with tunable optical characteristics

Sep 12, 2014

Researchers from RIKEN and the University of Tokyo have developed an organic dye molecule with tunable light-absorption and color characteristics. This development promises to open the door to the creation ...

How salt causes buildings to crumble

Sep 11, 2014

Salt crystals are often responsible when buildings start to show signs of aging. Researchers from the Institute for Building Materials have studied salt damage in greater depth and can now predict weathering ...

Ridding the sea and land from toxic plastics fragments

Sep 11, 2014

Plastic products made of PVC, Polystyrene and other prominent plastics are flooding the market. They are a growing threat to the environment, as they are found in the sea or dumped in land fills. But in a ...

User comments : 0